A systematic review and meta-analysis demonstrated that chromium picolinate supplementation could significantly reduce body mass index (BMI), fasting insulin, and free testosterone levels in PCOS patients, indicating improvements in metabolic disorders associated with the condition. This evidence concerns the gene INS and metabolic disease.